Unity Biotechnology Inc (UBX) is down 1.74% Friday In Premarket Trading

Unity Biotechnology Inc (UBX) is lower by Friday morning, with the stock losing -1.74% in pre-market trading to 1.69. UBX's short-term technical score of 43 indicates that the stock has traded less bullishly over the last month than 57% of stocks on the market. In the Biotechnology industry, which ranks 129 out of 146 industries, Unity Biotechnology Inc ranks higher than 63% of stocks. Unity Biotechnology Inc has remained neutral 0.00% over the past month, closing at $2.13 on November 17. During this period of time, the stock fell as low as $1.57 and as high as $2.26. UBX has an average analyst recommendation of Strong Buy. The company has an average price target of $6.50.

UBX has an Overall Score of 44. Find out what this means to you and get the rest of the rankings on UBX!

See Full UBX Report

Unity Biotechnology Inc has a Long-Term Technical rank of 10. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 90% of the market scoring higher. In the Biotechnology industry which is number 122 by this metric, UBX ranks better than 122% of stocks.

Important Dates for Investors in UBX:

-Unity Biotechnology Inc is set to release earnings on 2024-02-11. Over the last 12 months, the company has reported EPS of $-3.34. -We do not have a set dividend date for Unity Biotechnology Inc at this time. Click Here To Get The Full Report on Unity Biotechnology Inc (UBX)